A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2009
11/19/2009	WO2009139506A1 Combination of drugs having different physical properties into single dosage form
11/19/2009	WO2009139504A2 A solid pharmaceutical formulation
11/19/2009	WO2009139411A1 Transdermal preparation containing palonosetron
11/19/2009	WO2009139213A1 Pharmaceutical composition for external application containing prochlorperazine
11/19/2009	WO2009138962A1 Delivery system for an active ingredient
11/19/2009	WO2009138884A2 Compositions and methods for inhibiting gastric acid secretion
11/19/2009	WO2009138847A2 An improved process for the preparation of cefozopran
11/19/2009	WO2009138806A1 Novel liposome cocktail formulations containing doxorubicin and the potent multidrug resistance inhibitor amiodarone
11/19/2009	WO2009138737A1 Topical composition of opioid compound for use in wound healing
11/19/2009	WO2009138716A1 Compositions for the oral delivery of corticosteroids
11/19/2009	WO2009138642A1 Solid oral form with dual release profile, containing multiparticulates
11/19/2009	WO2009138477A2 Epithelial delivery
11/19/2009	WO2009138473A2 Intracellular antibody delivery
11/19/2009	WO2009138455A1 Enzyme composition for reducing the release of pharmaceutical active ingredients into the environment
11/19/2009	WO2009138224A1 Pharmaceutical composition comprising drospirenone
11/19/2009	WO2009138208A1 Process for manufacturing chewing gum having a coating layer, and the chewing gum obtainable by said process
11/19/2009	WO2009138198A2 Compositions comprising hydroxytyrosol for the preventive and curative treatment of intestinal tract disorders
11/19/2009	WO2009138170A2 Film-shaped preparation comprising oily substances for oral administration
11/19/2009	WO2009138042A1 A composition of glycoprotein hormone
11/19/2009	WO2009137897A1 Nanoparticles containing proteolytic enzymes for the treatment of peyronie's disease
11/19/2009	WO2009137890A1 Administrable compositions
11/19/2009	WO2009121039A3 Administration of benzodiazepine compositions
11/19/2009	WO2009114368A3 Activated nitric oxide donors and methods of making and using thereof
11/19/2009	WO2009108932A3 Selectin ligands useful in the diagnosis and treatment of cancer
11/19/2009	WO2009108865A3 Tablets and preparation thereof
11/19/2009	WO2009108577A3 Use of black soybean for treating ophthalmic diseases
11/19/2009	WO2009108005A3 Composition and method for screening active material used for the prevention and treatment of diabetes or obesity using senp2 and composition for the prevention and treatment of diabetes or obesity
11/19/2009	WO2009105165A3 Cardioplegia solution for cardiac surgery
11/19/2009	WO2009104939A3 Pharmaceutical preparation
11/19/2009	WO2009104054A3 Pharmaceutical compositions containing water-soluble derivatives of propofol and methods of administering same via pulmonary administration
11/19/2009	WO2009100422A3 Drug delivery system comprising microparticles and gelation system
11/19/2009	WO2009087665A3 Gastroretentive drug delivery system
11/19/2009	WO2009087658A3 Ketorolac tromethamine containing parenteral formulation
11/19/2009	WO2009065947A3 Pharmaceutical composition containing a zeolite/algae or zeolite/emulsion combination for the treatment of aids
11/19/2009	WO2009063491A3 Topical compositions for skincare
11/19/2009	WO2009048698A9 Co-solvent compositions and methods for improved delivery of dantrolene therapeutic agents
11/19/2009	WO2009034431A3 Controlled-release dosage forms for varenicline
11/19/2009	WO2008110741A8 Topical pharmaceutical formulation
11/19/2009	WO2006044086A8 Pool chemical tablet
11/19/2009	US20090287313 Tissue adhesive sealant
11/19/2009	US20090287228 Inorganic-organic melt-extruded hybrid yarns and fibrous composite medical devices thereof
11/19/2009	US20090286867 Compositions and methods of administering doxepin to mucosal tissue
11/19/2009	US20090286735 Method for administering glp-1 molecules
11/19/2009	US20090286715 Pharmaceutical Composition
11/19/2009	US20090285905 Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
11/19/2009	US20090285904 Enhanced antimicrobial activity of plant essential oils
11/19/2009	US20090285903 Methods for dendritic cell therapy using pharmacologically active microcarriers
11/19/2009	US20090285902 Dietary supplement composition for blood lipid health
11/19/2009	US20090285901 Polyamino acid for use as adjuvant
11/19/2009	US20090285900 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
11/19/2009	US20090285899 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
11/19/2009	US20090285898 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
11/19/2009	US20090285897 Rehydratable thiolated polysaccharide particles and sponge
11/19/2009	US20090285896 Bioabsorbable polyesteramides and uses thereof
11/19/2009	US20090285895 Pharmaceutical Formulation for Regulating the Timed Release of Biologically Active Compounds Based on a Polymer Matrix
11/19/2009	US20090285894 Micro-particles containing a 3-d polymeric structure
11/19/2009	US20090285893 Treatment of heart failure in women
11/19/2009	US20090285892 Methods and systems for expanding ac133+ cells and directing differentiation
11/19/2009	US20090285891 Pharmaceutical preparation for oral administration with controlled active ingredient release in the small intestine and method for its production
11/19/2009	US20090285890 Antimicrobial peroxidase compositions
11/19/2009	US20090285889 Modified release formulations of dihydropyridine compounds and methods of making same
11/19/2009	US20090285888 Derivatives of dihydroxyphenylalanine
11/19/2009	US20090285887 Pharmaceutical Composition Comprising A Plurality of Mini-Tablets Comprising A Factor XA Inhibitor
11/19/2009	US20090285886 Enhanced antimicrobial activity of plant essential oils
11/19/2009	US20090285885 Method of forming a drug nanocarrier having a magnetic shell
11/19/2009	US20090285884 cisplatin derivatives exhibit antitumor cell and/or antiparasitic activity, formed by complexing cisplatin in water and an organic solvent, with a ligand capable of bonding to the platinum of cisplatin and nitrogen dioxide gas; anticarcinogenic agents
11/19/2009	US20090285883 Identification of gastrointestinal, pancreatic and cancer stem cell markers and methods of use thereof
11/19/2009	US20090285882 Stabilized Liposome Compositions and Related Methods of Use
11/19/2009	US20090285881 Cationic lipids and uses thereof
11/19/2009	US20090285880 Dried reconstituted vesicle formation for pharmaceutical application
11/19/2009	US20090285879 Malaria prime/boost vaccines
11/19/2009	US20090285878 Compositions and methods for stabilizing liposomal drug formulations
11/19/2009	US20090285877 Percutaneous absorption preparation containing palonosetron
11/19/2009	US20090285875 Infused Sponge Delivery System
11/19/2009	US20090285867 Method for extemporaneous and reversible concentration of liposomes
11/19/2009	US20090285865 Palatable, solid oral formulations for male chemical sterilization
11/19/2009	US20090285864 Therapeutic formulation
11/19/2009	US20090285863 Coating Composition Comprising Starch
11/19/2009	US20090285862 Methods and composition for treatment of inflammatory pain
11/19/2009	US20090285833 Clostridium botulinum c3 exotransferase compositions and methods for treating tumour spreading
11/19/2009	US20090285802 Highly concentrated stabilized igm solution
11/19/2009	US20090285764 Azeotrope-Like Compositions of Tetrafluoropropene and Hydrofluorocarbons
11/19/2009	US20090285763 Infant aerosol drug delivery systems and methods
11/19/2009	US20090285753 Novel haptotactic peptides
11/19/2009	DE602004013348T2 Bukkale arzneimittelabgabe Buccal drug donation
11/19/2009	DE102008023345A1 Filmförmige Zubereitung mit öligen Substanzen zur oralen Verabreichung Preparation in film form with oily substances for oral administration
11/19/2009	DE102008023228A1 Nanoparticle comprising piezoelectric, pyroelectric or ferroelectric crystalline core material with electric dipole properties, useful as an agent for selective tissue therapy
11/19/2009	CA2761582A1 Oral formulations of cytidine analogs and methods of use thereof
11/19/2009	CA2725437A1 Compositions and methods for inhibiting gastric acid secretion
11/19/2009	CA2724472A1 Micelles for intracellular delivery of therapeutic agents
11/19/2009	CA2724196A1 Process for manufacturing chewing gum having a coating layer, and the chewing gum obtainable by said process
11/19/2009	CA2724191A1 Film-shaped preparation comprising oily substances for oral administration
11/19/2009	CA2724069A1 Medicament delivery device having an electronic circuit system
11/19/2009	CA2724009A1 Pulmonary delivery of a fluoroquinolone
11/19/2009	CA2724004A1 Administrable compositions
11/19/2009	CA2723649A1 Transnasal anticonvulsive pharmaceutical composition comprising poorly soluble anticonvulsant
11/19/2009	CA2723588A1 Intraocular drug delivery device and associated methods
11/19/2009	CA2723458A1 Controlled release corticosteroid compositions and methods for the treatment of otic disorders
11/19/2009	CA2722602A1 Stable pharmaceutical formulations
11/19/2009	CA2722244A1 A solid pharmaceutical formulation

1 ... 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 ... 2991